No abstract available
MeSH terms
-
Castleman Disease / complications*
-
Coagulants / therapeutic use
-
Cyclophosphamide / administration & dosage
-
Factor VIIa / therapeutic use
-
Fatal Outcome
-
Gallbladder Diseases / etiology
-
Hemophilia A / drug therapy
-
Hemophilia A / etiology*
-
Humans
-
Immunosuppressive Agents / administration & dosage
-
Male
-
Middle Aged
-
Recombinant Proteins / therapeutic use
-
Rupture
Substances
-
Coagulants
-
Immunosuppressive Agents
-
Recombinant Proteins
-
Cyclophosphamide
-
recombinant FVIIa
-
Factor VIIa
Supplementary concepts
-
Factor 8 deficiency, acquired